Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Marinova, Y. Slavova, P. Titorenkov, D. Kostadinov, M. Tafradjiiska, E. Goranov, D. Petrov (Sofia, Bulgaria). Clinicopathological prognostic factors in operated for pulmonary carcinoid tumor patients. Eur Respir J 2014; 44: Suppl. 58, 515

Member's Comments

No comment yet.

Related content which might interest you: Correlation between clinical and pathological factors in resected lung carcinoid tumours Source: International Congress 2016 – Special issues in thoracic surgery Year: 2016 Primary lung sarcomas and sarcomatoid carcinomas – Clinicopathological prognostic factors in operated patients Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Evaluation of lung cancer patients with distant organ metastasis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Clinicopathological prognostic factors in operated for small cell lung carcinoma or large cell neuroendocrine carcinoma patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Prognostic factors for survival in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Clinicopathological characteristics and treatment outcomes of pulmonary carcinosarcoma in eight patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Relationship between risk factors for lung cancer and tumor size Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Prevalence of molecular changes in resected pulmonary adenocarcinomas Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Indeterminate solitary pulmonary nodule: Surgical diagnosis and models for predicting malignancy Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Significance of age, tumor location and histological subtype in lung cancer with brain metastasis Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Survival of non small cell lung carcinoma patients with malignant pleural effusions Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Primary pulmonary sarcomatoid carcinoma: A case series Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Rare primary pulmonary tumors Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Clinical features and prognosis of multiple primary malignancies in patients with lung cancer Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Prognostic factors in non-small cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Prognostic value of EGFR mutation in NSCLC in surgical stage Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014